What are the implications of regulatory changes on personalized medicine in cancer treatment?
Regulatory changes have significant implications for personalized medicine in cancer treatment. The approval processes now favor therapies tailored to individual genetic profiles, allowing for more targeted and effective treatments. Companion diagnostics, which help identify the patients most likely to benefit from a specific therapy, are also receiving accelerated approvals. This fosters a more personalized approach to cancer care, improving outcomes and reducing adverse effects.
